A 16-amino-acid signalling peptide encoded by mitochondrial DNA.
PRODUCT PROFILE
MOTS-c
£35.64
MOTS-c is a small peptide made from genetic material inside mitochondria, the parts of cells that produce energy. Researchers study how it may help cells respond to exercise, low energy and metabolic stress. Most evidence is still from laboratory and animal work.
Why it is distinct
MOTS-c begins inside mitochondria and is studied for cell-wide energy adaptation, rather than directly targeting appetite receptors.
- Evidence stagePhase 2 clinical research
- AvailabilityAvailable · 30 in stock
- Batch recordPublished after verification
- DispatchConfirmed at checkout
30 in stock
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
MOTS-c is a small peptide made from genetic material inside mitochondria, the parts of cells that produce energy. Researchers study how it may help cells respond to exercise, low energy and metabolic stress. Most evidence is still from laboratory and animal work.
Research focus+
Research focuses on cellular energy use, insulin sensitivity, exercise response and how cells adapt when energy is limited.
How the mechanism differs+
Laboratory studies link it to AMPK energy sensing and changes in gene activity during metabolic stress.
Evidence and limitations+
Most evidence is from cells and animals, with limited human observational or exercise-response research. Clinical benefits are not established.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Research focuses on cellular energy use, insulin sensitivity, exercise response and how cells adapt when energy is limited.
Laboratory studies link it to AMPK energy sensing and changes in gene activity during metabolic stress.
MOTS-c begins inside mitochondria and is studied for cell-wide energy adaptation, rather than directly targeting appetite receptors.
Most evidence is from cells and animals, with limited human observational or exercise-response research. Clinical benefits are not established.
Educational research context only. This information is not dosage, administration or personal-use guidance.
CONTINUE EXPLORING
Related research perspectives.
Selected for useful comparison across neighbouring or contrasting research areas—not as combined-use guidance.
-
Clinical research
SS-31 (Elamipretide)
£29.9910 mgBatch file pendingDirectly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.
UnavailableAsk about availability -
Preclinical
BPC-157
£32.99Batch file pendingBPC-157 is mainly discussed around stomach and local tissue-repair models. TB-500 is instead studied for actin, cell movement…
Available · 30 in stockAdd to basket -
Phase 2 clinical research
GHK-Cu
£24.99Batch file pendingGHK-Cu is a copper complex. Pal-GHK has a fatty tail for topical formulas, while non-copper peptides use different…
Available · 50 in stockAdd to basket